Search clinical trials for: Dimethyltryptamin (DMT) & Harmine

Total 18481 results

Yale University

Active, not recruiting

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

Depression | Major Depressive Disorder

United States
Reconnect Labs

Completed

Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects (DHTP)

Healthy

Switzerland
Insel Gruppe AG, University Hospital Bern
Psychiatric University Hospital, Zurich

Recruiting

Molecular Imaging Study of Harmine/DMT: a Basic Research Approach (HaD-PET)

Neuropharmacological Investigation of Ayahuasca Constituents DMT and Harmine

Switzerland
University Hospital, Basel, Switzerland

Completed

Effects of Dimethyltryptamine in Healthy Subjects (DMT)

Healthy

Switzerland
Small Pharma Ltd

Completed

SPL026 With or Without SSRIs in Participants With MDD

Major Depressive Disorder

United Kingdom
University of California, Los Angeles
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Adaptive Interventions for Minimally Verbal Children With ASD in the Community (AIM-ASD)

Autism

United States
Usona Institute

Completed

Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers

Pharmacokinetics | Tolerability | Safety

United States
GH Research Ireland Limited

Completed

Safety of GH001 in Healthy Volunteers

Healthy Volunteers

Netherlands
GH Research Ireland Limited

Completed

Clinical Study of GH001 in Depression

Depression | Major Depressive Disorder | Treatment Resistant Depression

Netherlands
GH Research Ireland Limited

Recruiting

Phase 2 Clinical Trial of GH001 in Postpartum Depression

Postpartum Depression | Postnatal Depression

United Kingdom, Netherlands
GH Research Ireland Limited

Recruiting

Phase 2 Clinical Trial of GH001 in Bipolar II Disorder

Bipolar II Disorder

Netherlands, Germany
GH Research Ireland Limited

Completed

Pharmacokinetics of GH001 in Healthy Volunteers

Healthy Volunteers

Netherlands
GH Research Ireland Limited

Recruiting

A Trial of GH001 in Patients With Treatment-resistant Depression

Treatment-resistant Depression

Ireland, Germany, Czechia, Spain, Netherlands, Poland
GH Research Ireland Limited

Completed

Safety and Pharmacokinetics of GH002 in Healthy Volunteers

Healthy Volunteers

Netherlands
Small Pharma Ltd

Completed

SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients

Major Depressive Disorder

United Kingdom
Shirley Ryan AbilityLab

Completed

Ventilatory Muscle Training in Stroke

Stroke | Exercise Therapy | Pulmonary Ventilation

United States
Universidade Federal do Rio Grande do Norte

Completed

Safety and Tolerability of DMT in Healthy Adults

Healthy Volunteers | Safety Issues

Brazil
University Hospital, Basel, Switzerland

Completed

Acute Dose-dependent Effects of DMT in Healthy Subjects (DMT DR)

Healthy

Switzerland
Rennes University Hospital

Recruiting

Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP) (STOP-I-SEP)

Multiple Sclerosis

France
University of Helsinki
Helsinki University Central Hospital; City of Helsinki

Not yet recruiting

Efficacy of Music Therapy and Digital Music Rehabilitation in Dementia

Dementia

Finland
Biomind Labs Inc.
Universidade Federal do Rio Grande do Norte

Completed

Clinical Study of DMT in Healthy Adults

Healthy Volunteers

Brazil
Universidade Federal do Rio Grande do Norte

Completed

Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression

Depressive Disorder | Depression, Unipolar

Brazil
Algernon Pharmaceuticals
Centre for Human Drug Research, Netherlands

Active, not recruiting

Single and Repeat Doses of DMT in Healthy Subjects

Stroke

Netherlands
Psychiatric University Hospital, Zurich
University of Basel

Completed

Neurodynamics of Prosocial Emotional Processing Following Serotonergic Stimulation With N,N-Dimethyltryptamine (DMT) and Harmine in Healthy Subjects

Emotions | Mood | Cognitive Function 1, Social | Empathy

Switzerland
University Hospital, Basel, Switzerland

Not yet recruiting

Acute Dose-dependent Effects of DMT-bolus Applications in Healthy Subjects (DMT BDR-Study) (DMT BDR)

Healthy

Switzerland
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Not yet recruiting

The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)

Alcohol-Related Disorders | Alcohol Use | Alcohol Use Disorder (AUD)

United States
Biogen

Completed

Tecfidera and the Gut Microbiota (TECONGUT)

Multiple Sclerosis, Relapsing-Remitting

Norway
The University of Hong Kong
Tung Wah Group of Hospitals

Completed

Programme Evaluation on Effectiveness of The Use of Movement-based x 'Elderspirituality - Fu Le Mun Sum' Intervention to Support Elderly People With Depressive Symptoms

Depression in Old Age

Hong Kong
Amasya University

Completed

Dance and Movement Therapy in Patients With Schizophrenia (DMTinSchizo)

Schizophrenia | Disabilities Mental | Negative Symptoms in Schizophrenia | Dance Therapy

Turkey
Milan Scheidegger
University Medical Center Freiburg

Completed

Mindfulness and Psychedelics

Healthy Participants

Switzerland
Centre de Recherche de l'Institut Universitaire...

Completed

Dancing for Better Aging: Evaluating the Impact of a Dance/Movement Therapy (D/MT) Program for Older Adults

Aging

Canada
Nestlé

Completed

Glycemic Response in Persons With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Johns Hopkins University

Recruiting

Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought

Healthy

United States
Imperial College London

Recruiting

PsilOCD: A Pharmacological-Challenge Feasibility Study

Obsessive-Compulsive Disorder

United Kingdom
Joshua Woolley, MD, PhD

Completed

Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease (PDP)

Depression | Parkinson Disease | Anxiety

United States
Johns Hopkins University
Heffter Research Institute

Completed

Psychopharmacology of Psilocybin in Cancer Patients

Cancer | Anxiety | Depressive Symptoms

United States
Tanta University

Unknown

Benefits of Nigella Sativa in Children With Beta Thalassemia Major (Nigella)

Nigella Sativa With Beta Thalassemia Major

Egypt
University of California, San Francisco

Recruiting

Psilocybin Therapy for Depression in Bipolar II Disorder (BAP)

Bipolar II Disorder

United States
University of Washington
National Institute of Mental Health (NIMH)

Completed

Treatment of Suicidal Women With Borderline Personality Disorder

Suicide | Borderline Personality Disorder

United States
Max Nieuwdorp

Not yet recruiting

Effect of eHealth on AB Use of Children With Acute, Uncomplicated URTIs

Upper Respiratory Tract Infection

Netherlands
Beckley Psytech Limited

Completed

Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects

Pharmacokinetics in Healthy Adults

United Kingdom
Imperial College London

Active, not recruiting

Psilocybin in Patients With Fibromyalgia: EEG-measured Brain Biomarkers of Action (Psilopain)

Fibromyalgia

United Kingdom
Small Pharma Ltd

Completed

IM and IV SPL026 Drug Product in Healthy Participants

Major Depressive Disorder

United Kingdom
Centers for Disease Control and Prevention
Columbia University; New York City Department of Health and Mental Hygiene

Completed

An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment

Tuberculosis | Adherence, Medication | Drug-resistant Tuberculosis | Adherence, Patient

United States
Johns Hopkins University

Recruiting

Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder (PsiloMDDAUD)

Major Depressive Disorder | Alcohol Use Disorder

United States
University Ghent
University Hospital, Ghent; Research Foundation Flanders; the Flanders Institute... and other collaborators

Completed

Fecal Microbiota Transplantation for Parkinson's Disease

Parkinson Disease

Belgium
Novartis Pharmaceuticals

Recruiting

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation (SOSTOS)

Relapsing-Remitting Multiple Sclerosis

United States, Canada
Exsar Corporation

Suspended

Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease

Type I Gaucher Disease

United States
University of North Carolina, Chapel Hill
The Broad Foundation; Crohn's and Colitis Foundation; OpenBiome

Terminated

Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP)

Pouchitis

United States
Neuroscience Trials Australia
The Florey Institute of Neuroscience and Mental Health

Completed

Tenecteplase Versus Alteplase Before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK)

Ischemic Stroke

Australia, New Zealand

Search clinical trials for: Dimethyltryptamin (DMT) & Harmine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations